Ongoing trials of immunosuppression in myelodysplastic syndromes.
| Site . | Type of Immunosuppression . | Study Design . |
|---|---|---|
| Hanover, Germany | rATG | single arm (n > 20, ongoing) |
| Basel, Switzerland | rATG +CSA | randomized, multicenter (new) |
| London, United Kingdom | rATG | single arm (n = 30, stopped) |
| Houston, USA | hATG, vs. hATG+CSA vs. hATG+fludarabine | randomized (n = 21, ongoing) |
| Scandinavian MDS Group | hATG +CSA | single arm (n = 13, ongoing) |
| Multicenter, USA | rATG, supportive care | randomized, multicenter (new) |
| Bethesda, USA | hATG +CSA | single arm (new) |
| Abbreviations: rATG, rabbit antithymocyte globuline; hATG, horse antithymocyte globulin | ||
| Site . | Type of Immunosuppression . | Study Design . |
|---|---|---|
| Hanover, Germany | rATG | single arm (n > 20, ongoing) |
| Basel, Switzerland | rATG +CSA | randomized, multicenter (new) |
| London, United Kingdom | rATG | single arm (n = 30, stopped) |
| Houston, USA | hATG, vs. hATG+CSA vs. hATG+fludarabine | randomized (n = 21, ongoing) |
| Scandinavian MDS Group | hATG +CSA | single arm (n = 13, ongoing) |
| Multicenter, USA | rATG, supportive care | randomized, multicenter (new) |
| Bethesda, USA | hATG +CSA | single arm (new) |
| Abbreviations: rATG, rabbit antithymocyte globuline; hATG, horse antithymocyte globulin | ||